Sounds positive23 Feb 2010 13:19
RNS sounds optimistic. Nigel Parker CEO says 'We believe the body of evidence submitted is substantial and robust and overall in accordance with current international recommendations for glioma trials.' Even if they get knocked back again, ARK will definitely head north before the decision in 1 or 2 months. Reckon this will be over 20p soon and if it Cerepro does get accepted, then this will move a lot higher, maybe three times current sp. IMO